Ovid Therapeutics
OVID
OVID
75 hedge funds and large institutions have $54.7M invested in Ovid Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 74 → 75 (+1)
0.41% more ownership
Funds ownership: 64.87% → 65.28% (+0.41%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
75
Holding in Top 10
1
Calls
$47K
Puts
$13K
Top Buyers
| 1 | +$401K | |
| 2 | +$380K | |
| 3 | +$254K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$215K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$166K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$417K | |
| 3 | -$408K | |
| 4 |
FWM
FFT Wealth Management
Philadelphia,
Pennsylvania
|
-$377K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$202K |